Improving cancer prevention through HPV and HBV vaccination in Nigeria
Official title: US-Nigerian Cancer Control Center for Research on Implementation Science and Equity (C3-RISE)
Funded at Washington University · NIH-10931740 · Data updated 2026-11-12
This study is working to help more people in Nigeria get vaccinated against HPV and HBV to prevent cancer, using friendly community approaches to make the vaccines easier to access and understand.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $854,493 |
| NIH project number | 5U54CA284110-02 |
| Project ID | NIH-10931740 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals in Nigeria who are eligible for HPV and HBV vaccinations, particularly young people and those at risk of cervical and liver cancers.
✕Less likely to help
Patients outside of Nigeria or those who are not eligible for HPV or HBV vaccinations may not benefit from this research.
What this research studies
This research focuses on increasing the uptake of HPV and HBV vaccines in Nigeria to prevent cancer deaths. It employs innovative implementation science strategies, including community engagement and participatory methods, to ensure that these vaccines are accessible and widely accepted. The project aims to build local capacity and understanding of how to effectively implement and sustain cancer prevention interventions. By collaborating with various institutions, the research seeks to create a model that can be replicated in similar contexts.
Why it matters
Potential benefit: If successful, this research could significantly reduce preventable cancer deaths in Nigeria through increased vaccination rates.
How similar studies have gone: Previous research has shown success in implementing vaccination programs in similar contexts, indicating that this approach has potential for positive outcomes.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
Related research
Other NIH-funded projects on the same topics.
-
Improving colorectal cancer screening and follow-up care.
This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
How Poverty and the Environment Affect Heart Disease in Haiti and Beyond
This grant studies how poverty-related factors like food insecurity, stress, and pollution contribute to heart disease and aims to follow a large group of adults to better understand and prevent the disease.
-
Resilient HIV Implementation for LGBTQ Youth in Africa and Beyond
A program to help young people ages 15–24 who are at risk for or living with HIV, especially sexual and gender minority youths, access better HIV prevention and care through real-world health practice improvements.
-
Regional hub to speed up ending HIV with practical science
A regional collaboration will translate proven HIV interventions into real-world practice to reduce new infections across priority areas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.